Effects of antirejection therapies for early subclinical acute rejection in renal transplant protocol biopsies

Table 3 Changes in tubulitis and interstitial inflammation scores in patients with borderline changes and subclinical acute rejection diagnosed at the 3-month protocol biopsy

	Score at 3 months	Score at 1 year
Tubulitis (t score)
BL-o (n = 50)	1.16 ± 0.37^a	0.68 ± 0.71
BL-t (n = 33)	1.18 ± 0.39^b	0.45 ± 0.67
SAR (n = 20)	1.95 ± 0.76^a,b	0.60 ± 0.82
Interstitial inflammation (i score)
BL-o (n = 50)	0.68 ± 0.47^c	0.53 ± 0.65
BL-t (n = 33)	0.97 ± 0.47^d	0.36 ± 0.55
SAR (n = 20)	1.40 ± 0.82^c,d	0.80 ± 0.83

Data are presented as mean ± standard deviation.
BL-o borderline changes with observation and no antirejection therapies, BL-t borderline changes with antirejection therapies, SAR subclinical acute rejection
^ap < 0.001
^bp < 0.001
^cp < 0.001
^dp = 0.028

ISSN: 2059-1381